Teva to shutter Israeli R&D site in company reorganization | Fierce Biotech
An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017. REUTERS/Amir Cohen Stock Photo - Alamy
Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
Jewish Values Investors JLens Target Israeli Company – The Forward
What's Next For Teva Pharmaceutical Stock After A 17% Fall In A Month?
Teva Recalls Drug Vials, Shuts Facility Over Mold Concerns - TheStreet
Teva's Stock Price Surge Against Its Predictable Woes
Teva Pharmaceuticals - Wikiwand
Teva stock drops 13% as Tel Aviv trade begins - The Jerusalem Post
Exterior of the pharmaceutical manufacturing plant of Teva Pharmaceutical Industries located in Har Hotzvim also called Campus of Science-Rich Industries a high-tech industrial park located in northwest Jerusalem. Israel Stock Photo -
Teva (TEVA) Stock has Rebounded off its Lows, But It's Not a Buy | InvestorPlace
Israeli company Teva Pharmaceutical stocks drop nearly 18% - The Jerusalem Post
Buffett buys $358 million stake in Teva - Axios
Israeli authorities cut Teva some slack as foreign bribery case resolved amid other big problems | Fierce Pharma
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters
Exterior of the pharmaceutical manufacturing plant of Teva Pharmaceutical Industries located in Har Hotzvim also called Campus of Science-Rich Industries a high-tech industrial park located in northwest Jerusalem. Israel Stock Photo -
Teva Falls on Pre-Market Trading After Morgan Stanley Downgrade | Ctech
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
What's 'down' with Teva? - The Jerusalem Post
Teva Pharmaceutical to cut up to 6,000 jobs: Report
Teva Shares Hit by Opioid Fallout - Hamodia.com
With $40 million pay, Teva breaks from custom for turnaround - The Boston Globe
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
Teva shares take tumble after warning of bleak 2019 - Business - Haaretz.com
